KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Receivables - Other (2018 - 2024)

Amgen (AMGN) has 8 years of Receivables - Other data on record, last reported at $521.0 million in Q4 2024.

  • For Q4 2024, Receivables - Other rose 3.78% year-over-year to $521.0 million; the TTM value through Dec 2024 reached $521.0 million, up 3.78%, while the annual FY2024 figure was $521.0 million, 3.78% up from the prior year.
  • Receivables - Other reached $521.0 million in Q4 2024 per AMGN's latest filing, up from $502.0 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $700.0 million in Q4 2022 and bottomed at $164.0 million in Q4 2021.
  • Average Receivables - Other over 5 years is $420.6 million, with a median of $502.0 million recorded in 2023.
  • Peak YoY movement for Receivables - Other: soared 326.83% in 2022, then decreased 28.29% in 2023.
  • A 5-year view of Receivables - Other shows it stood at $216.0 million in 2020, then fell by 24.07% to $164.0 million in 2021, then soared by 326.83% to $700.0 million in 2022, then decreased by 28.29% to $502.0 million in 2023, then grew by 3.78% to $521.0 million in 2024.
  • Per Business Quant database, its latest 3 readings for Receivables - Other were $521.0 million in Q4 2024, $502.0 million in Q4 2023, and $700.0 million in Q4 2022.